7-Ethyl-10-hydroxycamptothecin - 98%, high purity , CAS No.86639-52-3

2 Citations
  • ≥98%
Item Number
E110128
Grouped product items
SKUSizeAvailabilityPrice Qty
E110128-100mg
100mg
In stock
$94.90
E110128-500mg
500mg
In stock
$177.90
E110128-1g
1g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$320.90
E110128-5g
5g
In stock
$1,441.90

DNA topoisomerase I inhibitor. Active metabolite of CPT-11.

View related series
quinolines

Basic Description

SynonymsUNII-0H43101T0J | BCP9000200 | 0H43101T0J | BP-24513 | CAMPTOTHECIN, 7-ETHYL-10-HYDROXY- | SN 38 lactone | AC-1357 | NCGC00167831-05 | Q-200299 | (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione | GTPL6925 | 1H-
Specifications & Purity98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads

Associated Targets(Human)

TOP1 Tclin DNA topoisomerase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488187375
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488187375
IUPAC Name (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
INCHI InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1
InChi Key FJHBVJOVLFPMQE-QFIPXVFZSA-N
Canonical SMILES CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O
Isomeric SMILES CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
WGK Germany 3
RTECS UQ0491000
Alternate CAS 86639-52-3
PubChem CID 104842
NSC Number 673596
MeSH Entry Terms 7 Ethyl 10 hydroxycamptothecin;7-ethyl-10-hydroxycamptothecin;Camptosar;Camptothecin 11;camptothecin-11;CPT 11;CPT-11;CPT11;irinotecan;irinotecan hydrochloride;Irrinotecan;NK012 compound;SN 38;SN 38 11;SN-38;SN-38-11;SN3811
Molecular Weight 392.4
Reaxy-Rn 4829984

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

12 results found

Lot NumberCertificate TypeDateItem
B2317760Certificate of AnalysisJan 07, 2023 E110128
B2317761Certificate of AnalysisJan 07, 2023 E110128
B2317767Certificate of AnalysisJan 07, 2023 E110128
B2317778Certificate of AnalysisJan 07, 2023 E110128
B2317803Certificate of AnalysisJan 07, 2023 E110128
B2317820Certificate of AnalysisJan 07, 2023 E110128
B2317862Certificate of AnalysisJan 07, 2023 E110128
I2207459Certificate of AnalysisJul 29, 2022 E110128
I2207460Certificate of AnalysisJul 29, 2022 E110128
I2207461Certificate of AnalysisJul 29, 2022 E110128
I2207462Certificate of AnalysisJul 29, 2022 E110128
K2327037Certificate of AnalysisJul 29, 2022 E110128

Show more⌵

Chemical and Physical Properties

Sensitivityheat sensitive
Specific Rotation[α]+20.0 to +30.0 deg(C=0.2, THF)
Melt Point(°C)217°C

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS08
Signal Danger
Hazard Statements

H301:Toxic if swallowed

H341:Suspected of causing genetic defects

Precautionary Statements

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P281:Use personal protective equipment as required.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

P318:if exposed or concerned, get medical advice.

WGK Germany 3
RTECS UQ0491000
Reaxy-Rn 4829984

Related Documents

Citations of This Product

1. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu.  (2023)  Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.  BIOMATERIALS,  301  (122259).  [PMID:37531777]
2. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang.  (2023)  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.  International Journal of Nanomedicine,      [PMID:28553107]

References

1. Peter S et al..  (2016)  Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I..  Nucleic Acids Res,      [PMID:27587582]
2. Winkler C et al..  (2021)  SLFN11 informs on standard of care and novel treatments in a wide range of cancer models..  Br J Cancer,  124  (5): (951-962).  [PMID:33339894]
3. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu.  (2023)  Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.  BIOMATERIALS,  301  (122259).  [PMID:37531777]
4. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang.  (2023)  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.  International Journal of Nanomedicine,      [PMID:28553107]

Solution Calculators